𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Induction-related cost of patients with acute myeloid leukaemia in France

✍ Scribed by Virginie Nerich; Bruno Lioure; Maryline Rave; Christian Recher; Arnaud Pigneux; Brigitte Witz; Martine Escoffre-Barbe; Marie-Pierre Moles; Eric Jourdan; Jean Yves Cahn; Marie-Christine Woronoff-Lemsi

Publisher
Springer Netherlands
Year
2011
Tongue
English
Weight
276 KB
Volume
33
Category
Article
ISSN
2210-7703

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Remission induction, consolidation and n
Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia
✍ Mehdi Hamadani; Farrukh T. Awan πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Abstract Chemotherapy regimens used for remission induction in AML have not changed significantly over the last several decades. However the recognition of the prognostic value of cytogenetics and genomics has been a major advance which is helping clarify the most optimal post‐remission consolid

P080 Incidence of FLT-3 mutations in Ira
P080 Incidence of FLT-3 mutations in Iranian patients with acute myeloid leukaemia
✍ F. Zaker; M. Mohammadi; A. Kazemi πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 58 KB

Mutations affecting NPM, FLT3 ITD and TKD were present in 25% (30/120), 22% (26/120) and 8/120 (7%), respectively. NPM mutations were most prevalent in patients with normal karyotype (24/52; 46%) and were associated with FLT3-ITD mutations (16/26; 62%). Regarding the prognostic significance of NPM a